Hypertension
Conditions
Keywords
Hypertension, Blood pressure, Telemedicine, Telemonitoring, Vital sign monitoring
Brief summary
The objective of this study is to calibrate the blood pressure measurements of the Pulsewave Health Monitor (PAD-2A) device to be within 5±8 mmHg of the average of the dual-observer measurements via an aneroid sphygmomanometer (reference device), as per the methodology described in the ISO 81060-2: AMD\_2020 protocol.
Detailed description
The plan for this study is to calibrate the blood pressure measurements of the PAD-2A device with the dual-observer blood pressure measurements via an aneroid sphygmomanometer (reference device), as per the ISO 81060-2: AMD\_2020 protocol. The data will be collected and analyzed in order to calibrate the PAD-2A device blood pressure measurements to be within 5±8 mmHg of the average of the dual-observer auscultatory blood pressure measurements by adjusting the device algorithm.
Interventions
This is an observational, comparison study of blood pressure measurements. The objective of this study is to calibrate the blood pressure measurements of the Pulsewave Health Monitor (PAD-2A) device to be within 5±8 mmHg of the average of the dual-observer auscultatory blood pressure measurements via an aneroid sphygmomanometer (reference device), as per the ISO 81060-2: AMD\_2020 universal protocol.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults ≥ 19 years of age (minimum 30% male/female) * Wrist circumference between 13.5 cm. - 23 cm. (5.3 in. - 9.1 in.): Specifically for this test device, the wrist size of the consented participants will be distributed accordingly for a Gaussian distribution: Lowest Octile: ≥ 13.5cm to \< 14.7cm Lower Quarter: ≥ 13.5cm to \< 15.9cm Lower-Middle Quarter: ≥ 15.9cm to \< 18.3cm Upper-Middle Quarter: ≥ 18.3cm to \< 20.7cm Upper Quarter: ≥ 20.7cm to ≤ 23.0cm Highest Octile: ≥ 21.9cm to ≤ 23.0cm ● Willing to volunteer to participate and to sign the study specific informed consent form
Exclusion criteria
* Wrist circumference less than 13.5 cm. (5.3 in.) or greater than 23 cm. (9.1 in) * Hand or body tremors * Irregular heart rhythm (bigeminy, trigeminy, isolated ventricular premature beat (VPB), atrial fibrillation) * Korotkoff sound K5 not audible * Pregnant * A musculoskeletal disorder that prevents a non-invasive device to be inflated/deflated on the arm * Unwilling to volunteer to participate and to sign the study specific informed consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Systolic Pressure | From the start of cuff inflation to the end of cuff deflation (approximately 60 seconds) | Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff blood pressure device (mmHg) |
| Diastolic Pressure | From the start of cuff inflation to the end of cuff deflation (approximately 60 seconds) | Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff blood pressure device (mmHg) |
Countries
Canada